Most cited papers in Histiocytic Disorders and Treatments
What are the most cited papers in Histiocytic Disorders and Treatments?
The most cited paper in Histiocytic Disorders and Treatments is "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms" (Joseph David Khoury et al., 2022), with 4,204 citations. Next come "Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin" (3,284) and "Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)" (2,436).
Showing 50 of 100 papers. Every paper with more than 420 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms Joseph David Khoury et al. · Leukemia | 22 Jun 2022 | 4,204 |
| 2 | Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin Yupeng Wang, Wenqing Gao, Xuyan Shi et al. · Nature | 28 Apr 2017 | 3,284 |
| 3 | Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) Christer Sundström, Kenneth Nilsson · International Journal of Cancer | 15 May 1976 | 2,436 |
| 4 | Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments] Jean Pierre Soulier, Laurence Grollet, Éric Oksenhendler et al. · Blood | 15 Aug 1995 | 2,200 |
| 5 | The Tuberous Sclerosis Complex Peter B. Crino, Katherine L. Nathanson, Elizabeth P. Henske · New England Journal of Medicine | 27 Sep 2006 | 1,793 |
| 6 | Cellular senescence mediates fibrotic pulmonary disease Marissa J. Schafer et al. · Nature Communications | 23 Feb 2017 | 1,642 |
| 7 | Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages Jean‐François Emile et al. · Blood | 10 Mar 2016 | 1,603 |
| 8 | A sarcoma involving the jaws in african children Denis P Burkitt · British journal of surgery | Nov 1958 | 1,331 |
| 9 | Recurrent BRAF mutations in Langerhans cell histiocytosis Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara A. Degar et al. · Blood | 2 Jun 2010 | 1,255 |
| 10 | Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Elliott Foucar, Juan Rosaí, R F Dorfman · PubMed | Feb 1990 | 1,249 |
| 11 | Terminology of nodular hepatocellular lesions Ian R. Wanless · Hepatology | Sep 1995 | 1,139 |
| 12 | Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria E. Steve Roach, Manuel Rodriguez Gomez, Hope Northrup · Journal of Child Neurology | Dec 1998 | 1,087 |
| 13 | Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis Robert J. Risdall, Robert W. McKenna, Mark E. Nesbit et al. · Cancer | Sep 1979 | 1,070 |
| 14 | Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture Rolf Renne, Weidong Zhong, BRIAN G. HERNDIER et al. · Nature Medicine | Mar 1996 | 1,045 |
| 15 | Kaposi's Sarcoma Karen Hamm Antman, Yuan Chang · New England Journal of Medicine | 6 Apr 2000 | 1,025 |
| 16 | Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease Cheryl L. Willman, Lambert Busque, Barbara B. Griffith et al. · New England Journal of Medicine | 21 Jul 1994 | 1,010 |
| 17 | Epstein-Barr virus: exploiting the immune system David A. Thorley‐Lawson · Nature reviews. Immunology | Oct 2001 | 943 |
| 18 | The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation Nancy Raab‐Traub, Kathy Flynn · Cell | Dec 1986 | 927 |
| 19 | Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease Kazuyuki Yoshizaki, Tadashi Matsuda, Naoki Nishimoto et al. · Blood | Sep 1989 | 906 |
| 20 | Kaposi's sarcoma and its associated herpesvirus Enrique A. Mesri, Ethel Cesarman, CHRIS H. BOSHOFF · Nature reviews. Cancer | 24 Sep 2010 | 896 |
| 21 | Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma Denise Whitby, C. Boshoff, T. Hatzioannou et al. · The Lancet | Sep 1995 | 884 |
| 22 | Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection Henri‐Jacques Delecluse, Ioannis Anagnostopoulos, F. E. Dallenbach et al. · Blood | 15 Feb 1997 | 868 |
| 23 | Tuberous sclerosis complex Elizabeth P. Henske, Sergiusz Jóźwiak, John Christopher Kingswood et al. · Nature Reviews Disease Primers | 26 May 2016 | 857 |
| 24 | Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal Nita Agar, Emma Wedgeworth, Siobhan L. Crichton et al. · Journal of Clinical Oncology | 21 Sep 2010 | 854 |
| 25 | Contemporary classification of histiocytic disorders Blaise E. Favara, Alfred C. Feller, Macro Pauli et al. · Medical and Pediatric Oncology | Sep 1997 | 843 |
| 26 | G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator Carlos Bais, Bianca Santomasso, Omar A. Coso et al. · Nature | 1998 | 842 |
| 27 | KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma Shou‐Jiang Gao, Lawrence Kingsley, Ming O. Li et al. · Nature Medicine | Aug 1996 | 816 |
| 28 | mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6 Francesca Nazio, Flavie Strappazzon, Manuela Antonioli et al. · Nature Cell Biology | 22 Mar 2013 | 790 |
| 29 | Inflammatory myofibroblastic tumours: where are we now? Briana C. Gleason, Jason L. Hornick · Journal of Clinical Pathology | 15 Oct 2007 | 760 |
| 30 | Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma Aarif Yusuf Khakoo, Shibani Pati, Stasia A. Anderson et al. · The Journal of Experimental Medicine | 24 Apr 2006 | 754 |
| 31 | Langerhans cell histiocytosis Douglas M. Howarth, Gerald S. Gilchrist, Brian P. Mullan et al. · Cancer | 15 May 1999 | 727 |
| 32 | An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder Michael B. Jordan, David A. Hildeman, John W. Kappler et al. · Blood | 13 Apr 2004 | 721 |
| 33 | Kaposi sarcoma Ethel Cesarman, Blossom Damania, Susan E. Krown et al. · Nature Reviews Disease Primers | 31 Jan 2019 | 718 |
| 34 | Erdheim-Chester Disease Clinical and Radiologic Characteristics of 59 Cases Catherine Veyssier-Belot, P. Cacoub, Dominique Caparros-Lefebvre et al. · Medicine | May 1996 | 712 |
| 35 | Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma Nicolas Dupin, Cyril Fisher, Paul Kellam et al. · Proceedings of the National Academy of Sciences | 13 Apr 1999 | 709 |
| 36 | Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years Riccardo Haupt, Milen Minkov, Itziar Astigarraga et al. · Pediatric Blood & Cancer | 25 Oct 2012 | 701 |
| 37 | High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses Julien Haroche et al. · Blood | 10 Aug 2012 | 701 |
| 38 | Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases Stefano Aldo Pileri et al. · Histopathology | Jul 2002 | 670 |
| 39 | HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma Nicolas Dupin, Tim Diss, Paul Kellam et al. · Blood | 15 Feb 2000 | 655 |
| 40 | Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome Youn H. Kim, Howard L. Liu, Serena Mraz‐Gernhard et al. · Archives of Dermatology | Jul 2003 | 654 |
| 41 | Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease Oussama Abla, Eric D. Jacobsen, Jennifer Lee Picarsic et al. · Blood | 2 May 2018 | 644 |
| 42 | IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway Dung‐Fang Lee et al. · Cell | Aug 2007 | 637 |
| 43 | Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study G de-Thé, A. Geser, Nicholas Day et al. · Nature | Aug 1978 | 615 |
| 44 | Epstein–Barr virus infection and nasopharyngeal carcinoma Sai Wah Tsao, Chi Man Tsang, Kwok Wai Lo · Philosophical Transactions of the Royal Society B Biological Sciences | 11 Sep 2017 | 611 |
| 45 | Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma Jason L. Hornick, Paola Dal Cin, Christopher D.�M. Fletcher · The American Journal of Surgical Pathology | Apr 2009 | 607 |
| 46 | Sinus histiocytosis with massive lymphadenopathy: A pseudolymphomatous benign disorder.Analysis of 34 cases Juan Rosaí, Ronald F. Dorfman · Cancer | Nov 1972 | 602 |
| 47 | IgG1 plasmacytosis in interleukin 6 transgenic mice. S Suematsu, Tadashi Matsuda, Katsuyuki Aozasa et al. · Proceedings of the National Academy of Sciences | Oct 1989 | 595 |
| 48 | Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease Eli L. Diamond, Lorenzo Dagna, David Michael Hyman et al. · Blood | 22 May 2014 | 591 |
| 49 | Familial hemophagocytic lymphohistiocytosis Gritta Janka · European Journal of Pediatrics | Sep 1983 | 582 |
| 50 | Langerhans-Cell Histiocytosis Carl E. Allen, Miriam Mérad, Kenneth L. McClain · New England Journal of Medicine | 29 Aug 2018 | 577 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.